98%
921
2 minutes
20
Background: Todani Type IVa choledochal cysts are rare congenital malformations involving both intrahepatic and extrahepatic bile ducts. Adult-onset, asymptomatic, and localized presentations are exceptionally uncommon and pose a surgical challenge, particularly when considering the extent of resection and reconstruction required.
Case Presentation: We report the case of a 24-year-old asymptomatic female who was incidentally diagnosed with a localized Todani Type IVa cyst involving the left hepatic lobe and the common bile duct. Imaging revealed segmental intrahepatic cystic dilatation confined to the left lobe, with the right hepatic system remaining unaffected. The patient underwent a successful left hepatectomy and complete excision of the extrahepatic bile duct, followed by a Roux-en-Y hepaticojejunostomy directly anastomosed to the right hepatic duct. She was discharged on postoperative day 3 in excellent condition.
Clinical Discussion: Unlike most reported cases involving diffuse or bilobar intrahepatic extension or complicated pediatric presentations, our patient had a rare, unilobar adult Type IVa cyst with no inflammatory or malignant features. The decision to perform partial hepatectomy was guided by precise preoperative imaging, allowing complete resection without the need for liver transplantation. This case highlights the role of anatomical localization and individualized surgical planning in managing select cases of Type IVa choledochal cysts.
Conclusion: This case illustrates a rare adult presentation of localized Todani Type IVa choledochal cyst, successfully treated with left hepatectomy and Roux-en-Y hepaticojejunostomy. It supports the use of tailored surgical strategies based on precise anatomical assessment, especially in asymptomatic patients with unilobar involvement.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijscr.2025.111850 | DOI Listing |
Lancet Oncol
September 2025
Department of Cancer Medicine, Gustave Roussy, Paris-Saclay University, Villejuif, France.
Background: No standard treatment exists for patients with platinum-refractory advanced type B3 thymoma and thymic carcinoma. In the PECATI trial, we sought to assess the antitumour activity and safety of lenvatinib plus pembrolizumab in this population.
Methods: In this single-arm phase 2 trial, we recruited participants from 11 hospitals in France, Italy, and Spain.
Int J Surg Case Rep
August 2025
Department of General Surgery of the Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic. Electronic address:
Background: Todani Type IVa choledochal cysts are rare congenital malformations involving both intrahepatic and extrahepatic bile ducts. Adult-onset, asymptomatic, and localized presentations are exceptionally uncommon and pose a surgical challenge, particularly when considering the extent of resection and reconstruction required.
Case Presentation: We report the case of a 24-year-old asymptomatic female who was incidentally diagnosed with a localized Todani Type IVa cyst involving the left hepatic lobe and the common bile duct.
Acta Chir Orthop Traumatol Cech
June 2025
Klinika detske a dospele ortopedie a traumatologie 2. lekarske fakulty Univerzity Karlovy a Fakultni nemocnice v Motole, Praha.
Purpose Of The Study: The study aims to evaluate the mid-term functional and subjective outcomes of treatment of the mallet finger with a bone fragment using the Ishiguro extension block pinning. The hypothesis was that this technique provides reliable and high-quality outcomes with a low complication rate.
Material And Methods: The study included 54 patients aged 7-17 years who underwent surgery at our department between 2017 and 2022.
Gynecol Oncol
August 2025
Department of Oncology, Johns Hopkins School of Medicine; Baltimore, MD, USA; Department of Gynecology/Obstetrics, Johns Hopkins School of Medicine; Baltimore, MD, USA; Department of Pathology, Johns Hopkins School of Medicine; Baltimore, MD, USA. Electronic address:
Objective: Since anti-tumor immunity is enhanced by vaccination of mice adjacent to human papillomavirus type 16 (HPV16+) tumors, we examined whether HPV16 L2E7E6 fusion protein (TA-CIN) vaccination in the thigh of HPV16+ cervical cancer patients would be more immunogenic than their arm.
Methods: HPV16+ cervical cancer (stage IB1-IVA) patients, who had completed standard-of-care treatment within the past year and absent evidence of disease (NED), were enrolled in a pilot study (NCT02405221). Participants were randomized 1:1 to receive three 100 μg TA-CIN monthly intramuscular immunizations either in the arm or thigh and followed for two years for safety (CTCAEv4.
Ann Surg Oncol
August 2025
Duke Cancer Institute, Durham, NC, USA.
Background: Whereas medullary thyroid cancer (MTC) is more common in female patients, studies have indicated that MTC is more aggressive in males. It is unknown whether sex-based differences in MTC outcomes are due to inherent tumor behavior or factors such as care characteristics.
Methods: Patients with MTC stages I to IV were identified using the National Cancer Database (2004-2020).